Stephen Christopher Linthwaite Insider Profile
4 Followers
Stephen Christopher Linthwaite, President & CEO at Standard BioTools, holds 328.47K shares in Standard BioTools (Ticker: LAB).
Stephen Christopher Linthwaite's Trading History
| LABStandard BioTools | Feb 24, 2022 | President & CEO | Uninformative Buy | 36.03K | $203.98K | |
LAB Insider Shares: 328.47K (0.00%) | ||||||
You May Also Like
Stephen Christopher Linthwaite insider profile FAQ
What is the percentage of profitable transactions made by Stephen Christopher Linthwaite?
The percentage of profitable transactions made by Stephen Christopher Linthwaite is 67%.
What is the average return per transaction made by Stephen Christopher Linthwaite?
The average return per transaction made by Stephen Christopher Linthwaite is 56.70%.
What stocks does Stephen Christopher Linthwaite hold?
Stephen Christopher Linthwaite holds: LAB stocks.
What was Stephen Christopher Linthwaite’s latest transaction?
Stephen Christopher Linthwaite’s latest transaction was an Uninformative Buy of $36.03K.
What was Stephen Christopher Linthwaite's most profitable transaction?
Stephen Christopher Linthwaite’s most profitable transaction was an Informative Buy of LAB stock on August 8, 2017. The return on the trade was 117.70%.
What is Stephen Christopher Linthwaite's role in Standard BioTools?
Stephen Christopher Linthwaite's role in Standard BioTools is President & CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
